Thursday, December 09, 2004

From CBC News:
Review of arthritis drugs raises questions about role of regulators
The Vioxx recall is prompting serious questions about the ability of government regulators to remove dangerous drugs from the market.

The arthritis drug Vioxx was pulled from the market on Sept 30. Now drug regulators in Canada, the U.S. and Europe are reviewing the safety of all arthritis drugs in the same class as Vioxx, called COX-2 inhibitors.

No comments: